期刊
CURRENT ALZHEIMER RESEARCH
卷 17, 期 12, 页码 1133-1144出版社
BENTHAM SCIENCE PUBL LTD
DOI: 10.2174/1567205018666210119151952
关键词
Microbiome; Alzheimer; amyloid; inflammation; saliva; biomarker
资金
- NIH [RF1AG069378, P20GM103442, 1R01AG042819, R01AG048993]
- NIH/NIGMS [P20GM113123, U54GM128729]
- UND SMHS funds
- U.S. Department of Agriculture, Agricultural Research Service project plan [3062-51000-053-00D]
Background: Beta amyloid (A beta) peptide containing plaque aggregations in the brain are a hallmark of Alzheimer's Disease (AD). However, A beta is produced by cell types outside of the brain suggesting that the peptide may serve a broad physiologic purpose. Objective: Based upon our prior work documenting expression of amyloid beta precursor protein (APP) in intestinal epithelium we hypothesized that salivary epithelium might also express APP and be a source of A beta. Methods: To begin testing this idea, we compared human age-matched control and AD salivary glands to C57BL/6 wild type, App(NL-G-F), and APP/PS1 mice. Results: Both male and female AD, App(NL-G-F), and APP/PS1 glands demonstrated robust APP and A beta immunoreactivity. Female App(NL-G-F) mice had significantly higher levels of pilocarpine stimulated A beta 1-42 compared to both wild type and APP/PS1 mice. No differences in male salivary A beta levels were detected. No significant differences in total pilocarpine stimulated saliva volumes were observed in any group. Both male and female App(NL-G-F) but not APP/PS1 mice demonstrated significant differences in oral microbiome phylum and genus abundance compared to wild type mice. Male, but not female, APP/PS1 and App(NL-G-F) mice had significantly thinner molar enamel compared to their wild type counterparts. Conclusion: These data support the idea that oral microbiome changes exist during AD in addition to changes in salivary A beta and oral health.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据